{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T10:06:02Z","timestamp":1774951562424,"version":"3.50.1"},"reference-count":26,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Invasive lobular carcinoma (ILC) is a breast cancer subtype with a controversial surgical management due to its diffuse infiltrative growth pattern and increased tendency for multicentricity. This study aimed to compare the effects of breast-conserving surgery (BCS) and mastectomy on long-term overall survival (OS) and progression-free survival (PFS) in patients diagnosed with ILC. Materials and Methods: In this single-center, retrospective, observational study, 255 patients with histopathologically confirmed ILC between 2017 and 2025 were included. Patients who underwent surgical treatment were divided into two groups according to the surgical approach: BCS (n = 94) and mastectomy (n = 141). Survival analyses were performed using the Kaplan\u2013Meier method, and comparisons between groups were assessed with the log-rank test. Factors affecting survival were evaluated using Cox regression analysis. Results: The median age of the patients was 53 years (range, 28\u201385), and the median follow-up duration was 31.8 months. Of the cases, 76.9% were classic-type ILC and 70.9% had stage I\u2013II disease. The rate of negative surgical margins was 87.6%. No statistically significant differences were observed between the BCS and mastectomy groups in terms of estimated median PFS (87.4 months vs. 86.7 months; p &gt; 0.05) or estimated median OS (87.7 months vs. 115.7 months; p &gt; 0.05). Multivariable analyses demonstrated that the type of surgery was not an independent prognostic factor for survival. Conclusions: This study shows that, with appropriate patient selection and adequate surgical margin control, BCS provides oncologic survival outcomes comparable to mastectomy in ILC. The choice of surgical approach should be individualized based on tumor biology, stage, and multidisciplinary evaluation rather than histological subtype alone.<\/jats:p>","DOI":"10.3390\/medicina62040645","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T13:40:52Z","timestamp":1774878052000},"page":"645","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Oncological Outcomes of Breast-Conserving Surgery Versus Mastectomy in Invasive Lobular Breast Cancer: A Single-Center Retrospective Study"],"prefix":"10.3390","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5867-8776","authenticated-orcid":false,"given":"Simay","family":"\u00c7okgezer","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Institute of Oncology, Istanbul University, 34093 Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1133-916X","authenticated-orcid":false,"given":"Aysel","family":"Safaraliyeva","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, 34093 Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3108-694X","authenticated-orcid":false,"given":"Sevde","family":"Topuz","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, 34093 Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0439-4794","authenticated-orcid":false,"given":"Muhammet","family":"\u015eenkal","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, 34093 Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5790-7066","authenticated-orcid":false,"given":"Naziye","family":"Ak","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Institute of Oncology, Istanbul University, 34093 Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didem","family":"Ta\u015ftekin","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Institute of Oncology, Istanbul University, 34093 Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u0131nar Mualla","family":"Saip","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Institute of Oncology, Istanbul University, 34093 Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.annonc.2025.07.008","article-title":"Clinical challenges and proposed solutions for patients with invasive lobular breast cancer","volume":"36","author":"Sawyer","year":"2025","journal-title":"Ann. Oncol."},{"key":"ref_2","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejso.2014.09.004","article-title":"Surgical management of lobular carcinoma from a national screening program: A retrospective analysis","volume":"41","author":"Sharma","year":"2015","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1245\/s10434-011-1907-9","article-title":"Lobular breast cancer: Same survival and local control compared with ductal cancer, but should both be treated the same way? Analysis of an institutional database over a 10-year period","volume":"19","author":"Fortunato","year":"2012","journal-title":"Ann. Surg. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ejso.2013.02.007","article-title":"Clinical-pathologic features, long term-outcome and surgical treatment in a large series of patients with invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC)","volume":"39","author":"Biglia","year":"2013","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.prp.2016.05.002","article-title":"Lobular breast cancer: Clinical, molecular and morphological characteristics","volume":"212","author":"Christgen","year":"2016","journal-title":"Pathol. Res. Pract."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1038\/s41379-022-01135-2","article-title":"Results of a worldwide survey on the currently used histopathological diagnostic criteria for invasive lobular breast cancer","volume":"35","author":"Christgen","year":"2022","journal-title":"Mod. Pathol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.critrevonc.2014.07.003","article-title":"Invasive lobular breast cancer and its variants: How special are they for systemic therapy decisions?","volume":"92","author":"Guiu","year":"2014","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13058-020-01384-6","article-title":"Invasive lobular carcinoma of the breast: The increasing importance of this special subtype","volume":"23","author":"Kalinowski","year":"2021","journal-title":"Breast Cancer Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1148\/radiol.2333031484","article-title":"Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer","volume":"233","author":"Berg","year":"2004","journal-title":"Radiology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-007-9528-5","article-title":"MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: A review of existing literature","volume":"107","author":"Mann","year":"2008","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3233\/BD-2009-0277","article-title":"Clinical presentation and surgical management of invasive lobular carcinoma of the breast","volume":"30","author":"Dedes","year":"2008","journal-title":"Breast Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.amjsurg.2020.08.026","article-title":"Surgical management of invasive lobular carcinoma: Is less more?","volume":"221","author":"Huynh","year":"2021","journal-title":"Am. J. Surg."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.amjsurg.2004.06.020","article-title":"Lumpectomy margins are affected by tumor size and histologic subtype but not by biopsy technique","volume":"188","author":"Chagpar","year":"2004","journal-title":"Am. J. Surg."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1200\/JCO.2005.09.046","article-title":"Advances in breast conservation therapy","volume":"23","author":"Newman","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_16","first-page":"111","article-title":"Breast conservation therapy confers survival and distant recurrence advantage over mastectomy for stage II Triple Negative Breast cancer","volume":"220","author":"Macfie","year":"2020","journal-title":"Am. J. Surg."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/PAS.0b013e3182918a2b","article-title":"Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry","volume":"37","author":"Dabbs","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1754-9485.12080","article-title":"Mammographic and ultrasound features of invasive lobular carcinoma of the breast","volume":"58","author":"Porter","year":"2014","journal-title":"J. Med. Imaging Radiat. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13058-015-0605-0","article-title":"Lobular breast cancer series: Imaging","volume":"17","author":"Johnson","year":"2015","journal-title":"Breast Cancer Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"7409","DOI":"10.1245\/s10434-024-15326-5","article-title":"Oncologic Safety of Immediate Oncoplastic Surgery Compared with Standard Breast-Conserving Surgery for Patients with Invasive Lobular Carcinoma","volume":"31","author":"Falade","year":"2024","journal-title":"Ann. Surg. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"102800","DOI":"10.1016\/j.ctrv.2025.103001","article-title":"Invasive lobular carcinoma: Strategies and perspectives from the lobular breast cancer research group","volume":"140","author":"Corso","year":"2025","journal-title":"Cancer Treat. Rev."},{"key":"ref_22","first-page":"1442","article-title":"Clinical Impacts of Histological Subtyping Primary Breast Cancer","volume":"22","author":"Arpino","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1245\/s10434-018-6682-4","article-title":"Breast Conservation and Negative Margins in Invasive Lobular Carcinoma: The Impact of Oncoplastic Surgery and Shave Margins in 358 Patients","volume":"25","author":"Mukhtar","year":"2018","journal-title":"Ann. Surg. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3390\/cancers17050766","article-title":"Superior survival and lower recurrence outcomes with breast-conserving surgery compared to mastectomy following neoadjuvant therapy in 607 breast cancer patients","volume":"17","author":"Gentile","year":"2025","journal-title":"Cancers"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"8197","DOI":"10.3390\/curroncol29110647","article-title":"Surgical Management of the Axilla in Invasive Lobular Carcinoma in the Z1071 Era: A Propensity-Score Matched Analysis of the National Cancer Database","volume":"29","author":"Sinner","year":"2022","journal-title":"Curr. Oncol."},{"key":"ref_26","first-page":"1","article-title":"Differences in sensitivity to neoadjuvant chemotherapy among invasive lobular and ductal carcinoma of the breast and implications on surgery\u2013A systematic review and meta-analysis","volume":"61","author":"Davey","year":"2022","journal-title":"Breast"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/4\/645\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T09:15:47Z","timestamp":1774948547000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/4\/645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":26,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["medicina62040645"],"URL":"https:\/\/doi.org\/10.3390\/medicina62040645","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,28]]}}}